Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training
Spinal Cord Injuries
About this trial
This is an interventional treatment trial for Spinal Cord Injuries focused on measuring Spinal cord stimulation, Pelvic floor physiotherapy, Incontinence, Bladder overactivity, Neurogenic detrusor overactivity
Eligibility Criteria
Inclusion Criteria:
- Supra-sacral spinal cord injury over 6 months ago
- Previous urodynamics and management by the Neuro-urology Consultants
- Proven NDO from latest urodynamics
Exclusion Criteria:
- Participants under 16 years of age
- Non-stable SCI or metastatic cord disease
- Intra-detrusor botulinum toxin injections in previous 6 months
- Bladder infection on day of investigation
- Pregnant or trying for a baby (females)
- Cardiac pacemaker, bladder stimulator or baclofen pump in situ
- Metal work at thoraco-lumbar level of stimulation
- Poorly controlled Autonomic Dysreflexia
- Currently involved in a clinical trial
- Previous surgical intervention on bladder/sphincters
- Active sepsis
- Poorly controlled epilepsy. Acceptable where epilepsy is controlled by drugs or there have been no fits experienced for a reasonable period
- Patients with a cancerous tumour in the area of the electrical stimulation
- Patients without the capacity to consent
Sites / Locations
- Royal National Orthopaedic HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Bladder and Pelvic Floor Muscle Training
Control
Participants randomised to the intervention group will complete an 8-week bladder and PFMT programme, both at the LSCIC and at home. They will be invited to 3 face-to-face follow up appointments over the 8-weeks, where they will meet with a physiotherapist to check their technique and monitor their progress. At home participants will receive a daily text reminder to complete their PFM training, they will also receive a weekly phone call from a member of the research team who will check how they are managing and whether they have any questions. At the end of the programme, participants will be asked to repeat the questionnaires and have their pelvic floor re-assessed. Following this, they will complete the urodynamic investigation with tSCS.
Participants randomised to the control group will continue with their usual care for 8-weeks. They will return to repeat their baseline questionnaires and have their pelvic floor re-assessed. Finally, they will complete tSCS bladder filling and emptying cycles with urodynamics.